Pfizer in the spotlight

Oral obesity treatments & competitive landscape assessment in GLP-1 market

Biotech is bouncing back from the FTC news that raised concerns last week over M&A activity (read details here). Today, weight loss names are in the spotlight and adding hype to the gigantic market opportunity. Pfizer had data published on its oral GLP-1 weight loss drug in the medical journal JAMA. Although this data was not new, headlines made compari…